Find your next paid study

Novartis PharmaceuticalsNCT07604571

~$150 – $4,200

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Trial to Compare the Efficacy and Safety of a Fixed Dose of SEP-363856 to Placebo in the Treatment of Adults With Generalized Anxiety Disorder

This is a global, phase 3, randomized, double-blind, parallel-group, 2-arm, placebo controlled, multicenter trial designed to compare the efficacy, safety and …

Generalized Anxiety Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07767903

~$50 – $2,100

Actual pay is set by the research site.

DepressionPhysical Inactivity

Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers.

This study develops and tests a dynamic workplace-based depression intervention that is tailored to the specific social and behavioral needs of low-wage hospit…

San Diego State UniversityNCT06753123

~$10 – $750

Actual pay is set by the research site.

C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States

The purpose of the CASCADE-3002 project is to improve access to cervical cancer screening among women with Human Immunodeficiency Virus (HIV) receiving care at…

Human Immunodeficiency Virus (HIV)Human Papillomavirus (HPV)Cervical Cancer+1 more

UNC Lineberger Comprehensive Cancer CenterNCT07520188

~$10 – $750

Actual pay is set by the research site.

Benign Prostatic Hyperplasia (BPH)

A Prospective Randomized Pivotal Trial of the ALPFA Medical Prostate Ablation System Compared With Cystoscopy in Men With Symptomatic Benign Prostatic Hyperplasia

The main goal of this study is to evaluate the ALPFA GRAIL™ Pulsed Field Ablation (PFA) System for treatment of enlarged prostate (BPH) symptoms. The study wil…

Generalized Anxiety Disorder

Actual pay is set by the research site.

ALPFA MedicalNCT07592299

Phase 3

A Phase 3, Multicenter, Open-Label Extension Trial to Evaluate the Safety and Tolerability of SEP-363856 in the Treatment of Adults With Generalized Anxiety Disorder

This is a global, Phase 3, multicenter, open-label extension trial designed to evaluate the long-term safety, tolerability and efficacy of SEP-363856 administe…

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07786454

~$50 – $2,100

Actual pay is set by the research site.

HIV PreventionSubstance Use

Technology Enhanced Substance Use and HIV Service Navigation for Justice-Involved Young Adults

This study is designed to test Project LYNX, a program designed to help young adults (ages 18-29) with recent criminal legal system involvement can find and ge…

University of PittsburghNCT07599722

~$10 – $750

Actual pay is set by the research site.

Phase 1

A Phase 1b, Open-label Trial to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of NDI-5001 in a Capsule Following Daily Oral Doses to Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus

The primary purpose of this trial is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NDI-5001 administered as a capsu…

Diabetes Insipidus

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07525960

~$150 – $4,200

Actual pay is set by the research site.

Normal PhysiologyHealthy VolunteersPain

Sociocultural & Biobehavioral Influences on Pain Expression and Assessment

Objective The current proposal investigates behavioral, psychophysiological, and social processes that may help explain biases and disparate outcomes in pain.…

National Center for Complementary and Integrative Health (NCCIH)NCT03258580

Actual pay is set by the research site.

Management of Postoperative Pain After Cesarean Delivery Using Non-pharmacological Analgesic Device, NeuroCuple™

This will be a single-center, sham-controlled, 3 arms, randomized (1:1:1) prospective study in females undergoing cesarean delivery to investigate the impact o…

PainAnalgesiaPregnancy

Inova Health Care ServicesNCT07185425

Actual pay is set by the research site.

A Prospective, Multi-Center, Open-Label Clinical Investigation of the Cleaner Vac® Thrombectomy System for Treatment of Lower Extremity Proximal Deep Vein Thrombosis (DVT)

The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac® Thrombectomy System for the treatment of t…

Deep Vein Thrombosis (DVT)Thrombus in the Peripheral Venous VasculatureVenous Embolism+1 more

Argon Medical DevicesNCT07102160

Actual pay is set by the research site.

Phase 3

Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), Compared With Topotecan in Participants With Relapsed Small Cell Lung Cancer (SCLC)

In this study researchers are testing Risvutatug rezetecan also known as (Ris-Rez) a new medicine that targets specific proteins (B7-H3) on cancer cells, there…

Neoplasms, Lung